NCT06131385 Registration of Intravenous Thrombolysis for Acute Ischemic Stroke in Southwestern China（IVTIS）
| NCT ID | NCT06131385 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zhengzhou Yuan |
| Condition | Stroke, Acute |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2023-11-20 |
| Primary Completion | 2045-12-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2023-11-20 with a primary completion date of 2045-12-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to observe the safety and effectiveness of intravenous thrombolysis for acute ischemic stroke in real-world clinical practice.
Eligibility Criteria
Inclusion Criteria: * The patient was diagnosed with acute ischemic stroke and received intravenous thrombolysis. Exclusion Criteria: * No additional exclusion criteria.
Contact & Investigator
Zhengzhou Yuan
STUDY CHAIR
Department of Neurology, Affiliated Hospital of Southwest Medical University, Lu
Frequently Asked Questions
Who can join the NCT06131385 clinical trial?
This trial is open to participants of all sexes, studying Stroke, Acute. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06131385 currently recruiting?
Yes, NCT06131385 is actively recruiting participants. Contact the research team at coneuro@163.com for enrollment information.
Where is the NCT06131385 trial being conducted?
This trial is being conducted at Luzhou, China.
Who is sponsoring the NCT06131385 clinical trial?
NCT06131385 is sponsored by Zhengzhou Yuan. The principal investigator is Zhengzhou Yuan at Department of Neurology, Affiliated Hospital of Southwest Medical University, Lu. The trial plans to enroll 3,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.